CASI Pharmaceuticals
CASI
#10377
Rank
NZ$7.2 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-91.06%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -NZ$81.48 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$26.84 Million. In 2024 the company made an earning of -NZ$64.35 Million a decrease over its 2023 earnings that were of -NZ$44.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$81.48 Million26.61%
2024 -NZ$64.35 Million44.35%
2023 -NZ$44.58 Million-29.55%
2022 -NZ$63.27 Million4.43%
2021 -NZ$60.59 Million-24.56%
2020 -NZ$80.31 Million4.74%
2019 -NZ$76.68 Million65.13%
2018 -NZ$46.44 Million155.07%
2017 -NZ$18.21 Million13.93%
2016 -NZ$15.98 Million31.18%
2015 -NZ$12.19 Million-72.5%
2014 -NZ$44.29 Million356.62%
2013 -NZ$9.7 Million-60.55%
2012 -NZ$24.59 Million218.41%
2011 -NZ$7.73 Million0.74%
2010 -NZ$7.67 Million-32.54%
2009 -NZ$11.37 Million-66.98%
2008 -NZ$34.41 Million-14.22%
2007 -NZ$40.12 Million7.04%
2006 -NZ$37.48 Million27.95%
2005 -NZ$29.29 Million4.51%
2004 -NZ$28.03 Million-15.84%
2003 -NZ$33.3 Million-55.29%
2002 -NZ$74.49 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$85.73 Million31.56%
1999 -NZ$65.17 Million145.56%
1998 -NZ$26.54 Million76.4%
1997 -NZ$15.05 Million36.92%
1996 -NZ$10.99 Million